Pernilla Lagergren

Pernilla Lagergren

Professor
Telefon: +46852482758
Besöksadress: Blombäcks väg 23, plan 4, 17177 Stockholm
Postadress: K1 Molekylär medicin och kirurgi, K1 MMK Kirurgisk vårdvetenskap, 171 76 Stockholm

Om mig

  • Forskargruppsledare för gruppen Kirurgisk vårdvetenskap

    Pernilla Lagergren (f Viklund) blev legitimerad sjuksköterska 1999 och medicine doktor 2006 på KI. Därefter genomförde hon en post-doc period under 1½ år vid University of Bristol, England 2006-2007. Hon blev docent 2010 och innehar sedan 2011 en heltidstjänst som professor vid KI. I mars 2018 tillträdde Lagergren en tjänst som professor vid Imperial College London i England på deltidsbasis. Sedan 2026 har hon en deltidstjänst som legitimerad sjuksköterska på Tema Cancer, Karolinska Universitetssjukhuset.

Forskningsbeskrivning

  • Pernilla leder sin egen forskargrupp inom kirurgisk vårdvetenskap. Hennes forskning fokuserar på matstrups- och magsäckscancer, med särskilt fokus på patientrapporterade utfallsmått och stödjande vård efter behandling. Dessutom utvärderar hon om hälsorelaterad livskvalitet (HRQL) kan användas som en prognostisk faktor. Vidare omfattar hennes forskning metodutveckling av användning och hantering av HRQL-data med syftet att underlätta tolkningen av patientrapporterade utfall och förbättra utvärderingen av potentiella störfaktorer.

    Syftet är att bättre förstå patienters och deras närståendes erfarenheter, symtom och livskvalitet efter kurativ behandling, samt att identifiera ouppfyllda behov inom uppföljningsvården.

    Pernilla och hennes grupp arbetar med en stor nationell kohortstudie (OSCAR-studien) med >400 patienter som följs upp regelbundet under 12 år med nästan 500 patientrapporterade utfallsfrågor. Denna kohort har varit en huvudsaklig källa och grund för utvecklingen av en digital plattform (RECapp-plattformen) som är utformad för att stödja patienter i efterbehandlingsfasen och som nu ska testas i en nationell randomiserad kontrollerad studie.

    Forskargruppen främjar aktivt patientmedverkan i forskning och har haft en etablerad patientpartnerskapsgrupp sedan 2016.

    Slutligen syftar denna forskning till att bidra till en mer personcentrerad, responsiv och jämlik vård för patienter som återhämtar sig från matstrups- och magsäckscancer, samt till att bättre stödja deras familjer.

Undervisning

  • Docent i vårdvetenskap 2010

Artiklar

Alla övriga publikationer

Forskningsbidrag

  • Swedish Research Council
    1 January 2024 - 31 December 2026
    Background: The recovery after treatment of oesophageal and gastric cancer is complex, long, and incomplete. Patients have a “left alone” feeling after treatment and urge individualised support. The value of regular appointments with healthcare is criticised. Aim: To test our interactive smartphone application, named RECAPP, for monitoring of patients and informing them if and when there is a need for specific self-managed interventions, contact healthcare or no action required. RECAPP aims to help increase patients’ autonomy in symptom management and rehabilitation and thereby improving their daily lives and cancer survivorship.Method: RECAPP is developed using machine learning methods, based on data from of our nationwide and comprehensive cohort study. In this project, RECAPP will first be tested in 30 patients and adjusted as needed. Thereafter, we will conduct a nationwide randomised clinical trial of 250 oesophageal and gastric cancer patients. Half of patients will use RECAPP for 6 months while the other half follows standard of care. The primary outcome is reduction in symptom burden. Secondary outcomes are health-related quality of life, symptoms, weight development, patient empowerment, self-efficacy, survival, family caregiver burden and cost-effectiveness.Relevance: If RECAPP is proven to be a valuable tool in the follow-up management of these patients, it will be implemented in clinical practice for the benefit of patients, family caregivers and healthcare.
  • Swedish Research Council
    1 January 2021 - 31 December 2023
  • Swedish Research Council
    1 December 2019 - 31 December 2023
  • Central Norway Regional Health Authority
    1 January 2019 - 31 December 2022
  • The way forward after surgery for esophageal cancer
    Swedish Cancer Society
    1 January 2018
    Esophageal cancer has a worse prognosis than most tumor diseases and it often requires a very extensive surgery for chance of cure. The recovery after surgery is often long, troublesome and incomplete. It is important to identify influential factors that have a negative effect on the patient's quality of life after the operation. Weight loss and eating difficulties are central problems of the patients after surgery that need to be counteracted. Esophageal cancer is also a "family disease" and it is of great importance to examine the needs of relatives. The project is based on three nation-wide Swedish data collections on patients who are operated on for esophageal cancer. A group of patients participate in the planning of the studies. In a clinical trial, a 12-week physical exercise program is tested to counter muscle loss and improve quality of life. Several patient-reported measures such as quality of life, stress, anxiety, depression and weight are collected / measured from repeatedly after surgery. Furthermore, data on the patient, tumor, treatment, care time and survival are collected. The patient's relatives participate by answering several questions in order to improve their situation as well. Through studies of high scientific quality about important issues for patients, we want to demonstrate ways to how the healthcare system can provide the opportunity for better recovery in patients undergoing surgery for esophageal cancer and support for their relatives. Factors that affect the recovery should be identifiable at an early stage and guide an individual follow-up with targeted measures, including physical activity. This project can lead to patients who are operated for esophageal cancer receiving the support and help they need to optimize their quality of life and adaptation to post-operative life.
  • Swedish Research Council
    1 January 2018 - 31 December 2020
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2018 - 31 December 2020
  • Central Norway Regional Health Authority
    1 January 2018
    Celiac disease HUNT4<br/><br/>Celiac disease is a disease that occurs frequently in the West, but still there is a lot we do not know about the disease. With this project we will try to find out more about the incidence, quality of life and challenges related to celiac disease and study whether it is possible to diagnose the disease only using blood tests.Celiac disease is a disease of the small intestine caused by gluten in wheat, barley and rye in genetically predisposed individuals. Celiac disease is frequent in the West and is characterized by diarrhea, weight loss and a lack of vitamins and minerals. The diagnosis is made by findings on blood tests and tissue samples from the duodenum. The incidence in Norway today is unknown, but is expected to be 1%. It is believed that one or more triggering factors are needed for the disease to develop in genetically predisposed people, but these factors are largely unknown. Celiac disease causes discomfort and changes in lifestyle in those affected, but how this affects the quality of life is little known. In this project, we will investigate the prevalence of celiac disease by blood test testing of the participants in HUNT4. Participants suspected of having celiac disease will be invited to gastroscopy with tissue samples to confirm the disease. Participants will then be invited to participate in a study on quality of life and challenges related to celiac disease. By linking to national registries, we will investigate how many people have already been diagnosed with celiac disease and how many have not been diagnosed before. We will also investigate whether celiac disease can be diagnosed only using blood tests, that is, without a stomach examination. This is already done in children, but not in adults. This will spare patients the troublesome examination that gastroscopy can be and it will save society the costs of gastroscopy. <br/>Main objective: In this project, we want to study the prevalence of celiac disease in a general Norwegian population. We will also investigate whether celiac disease can be diagnosed only using blood tests. Sub-goal: In addition, we want to study the incidence of undiagnosed cases of the disease in the population and the incidence of related symptoms, deficiency conditions and comorbidities. We also want to study the patients' experience of the disease and their health-related quality of life. <br/>Expected benefit for patients and relatives: This project will reveal the incidence of celiac disease in a general Norwegian population and the incidence of undiagnosed cases of celiac disease. This will have great transfer value to the entire Norwegian population. Among the HUNT participants, we will be able to identify individuals with celiac disease, so that dietary treatment can be started and complaints and deficiency conditions related to celiac disease can be treated. In this project, we have made contact with the user organization Norwegian Celiac Association and a representative from the association is an employee in the project. On behalf of its members, the Norwegian Celiac Association has wanted to focus on the complaints and challenges experienced by users with celiac disease, including challenges related to the gluten-free diet and general health complaints. We therefore want to identify problem areas for users through questionnaires and interviews, in addition to general measures of health-related quality of life for users. This can be used to identify problem areas for users, which can then be prevented and treated through increased attention to these problems. This can also be of great importance for relatives of users, especially in the case of celiac disease in children. If we can show that celiac disease can be diagnosed only with the help of blood tests also in adults, this could have great clinical significance and change celiac disease diagnostics.<br/>
  • For a better life after surgery for esophageal cancer
    Swedish Cancer Society
    1 January 2017
    Esophageal cancer has a worse prognosis than most tumor diseases, and it often requires a very extensive surgery for cure and recovery after surgery is often long, cumbersome and incomplete. Weight loss and eating difficulties are central problems after the operation and therefore important to counteract. It is important to identify factors that have a negative effect on the patient's quality of life after surgery. Cancer is also a "family disease" and it is of great importance to examine the needs of relatives. The project is based on three nation-wide Swedish data collections as well as a data collection at a large center for esophageal cancer in London on patients undergoing surgery for esophageal cancer. We shall In a clinical trial test whether a physical exercise program can counter muscle loss. Data on several patient-reported measures such as quality of life, stress, anxiety, depression and weight are available from repeatedly after surgery. Furthermore, data on the patient, tumor, treatment, care time and survival are collected. The patient's relatives are invited to answer several questions in order to improve their situation as well. Through studies of high scientific quality about important issues for patients, we want to demonstrate ways to how the healthcare system can provide the opportunity for better recovery in patients undergoing surgery for esophageal cancer and support for their relatives. Factors that affect the recovery should be identifiable at an early stage and guide an individualized follow-up with targeted measures, among other things. physical activity. This project can lead to patients who are operated for esophageal cancer receiving the support and help they need to optimize their quality of life and adaptation to post-operative life.
  • Swedish Research Council for Health Working Life and Welfare
    1 January 2017 - 31 December 2019
  • For a better life after surgery for esophageal cancer
    Swedish Cancer Society
    1 January 2016
    Esophageal cancer has a worse prognosis than most tumor diseases, and it often requires a very extensive surgery for cure and recovery after surgery is often long, cumbersome and incomplete. Weight loss and eating difficulties are central problems after the operation and therefore important to counteract. It is important to identify factors that have a negative effect on the patient's quality of life after surgery. Cancer is also a "family disease" and it is of great importance to examine the needs of relatives. The project is based on three nation-wide Swedish data collections as well as a data collection at a large center for esophageal cancer in London on patients undergoing surgery for esophageal cancer. We shall In a clinical trial test whether a physical exercise program can counter muscle loss. Data on several patient-reported measures such as quality of life, stress, anxiety, depression and weight are available from repeatedly after surgery. Furthermore, data on the patient, tumor, treatment, care time and survival are collected. The patient's relatives are invited to answer several questions in order to improve their situation as well. Through studies of high scientific quality about important issues for patients, we want to demonstrate ways to how the healthcare system can provide the opportunity for better recovery in patients undergoing surgery for esophageal cancer and support for their relatives. Factors that affect the recovery should be identifiable at an early stage and guide an individualized follow-up with targeted measures, among other things. physical activity. This project can lead to patients who are operated for esophageal cancer receiving the support and help they need to optimize their quality of life and adaptation to post-operative life.
  • Swedish Research Council
    1 January 2016 - 31 December 2017
  • For a better life after surgery for esophageal cancer
    Swedish Cancer Society
    1 January 2015
    Esophageal cancer has a worse prognosis than most tumor diseases, and it often requires a very extensive surgery for cure and recovery after surgery is often long, cumbersome and incomplete. Weight loss and eating difficulties are central problems after the operation and therefore important to counteract. It is important to identify factors that have a negative effect on the patient's quality of life after surgery. Cancer is also a "family disease" and it is of great importance to examine the needs of relatives. The project is based on three nation-wide Swedish data collections as well as a data collection at a large center for esophageal cancer in London on patients undergoing surgery for esophageal cancer. We shall In a clinical trial test whether a physical exercise program can counter muscle loss. Data on several patient-reported measures such as quality of life, stress, anxiety, depression and weight are available from repeatedly after surgery. Furthermore, data on the patient, tumor, treatment, care time and survival are collected. The patient's relatives are invited to answer several questions in order to improve their situation as well. Through studies of high scientific quality about important issues for patients, we want to demonstrate ways to how the healthcare system can provide the opportunity for better recovery in patients undergoing surgery for esophageal cancer and support for their relatives. Factors that affect the recovery should be identifiable at an early stage and guide an individualized follow-up with targeted measures, among other things. physical activity. This project can lead to patients who are operated for esophageal cancer receiving the support and help they need to optimize their quality of life and adaptation to post-operative life.
  • Patient experiences after surgery for esophageal cancer - guide to improved recovery and life situation
    Swedish Cancer Society
    1 January 2014
    Esophageal cancer has a worse prognosis than most tumor diseases and a very extensive surgery is required for chance of cure. Patients often suffer from severe symptoms and a number of other problems long after surgery. It is of great importance to identify factors that have a negative effect on the patient's quality of life after surgery. The knowledge is very poor about what effects the diagnosis and surgery have on psychological aspects such as stress, anxiety and depression. The project is based partly on a nation-wide clinical study in Sweden and an ongoing clinical data collection at a high-volume hospital in London on patients undergoing surgery for esophageal cancer. Data on quality of life, stress, anxiety and depression as well as weight development measured at most repeated occasions after surgery will be available. In addition, detailed information on the patient, tumor, treatment, care time and survival is collected. Through studies of high scientific quality, we want to demonstrate ways to how the health care system can provide the opportunity for a better life in patients undergoing surgery for esophageal cancer. Factors that affect the recovery can be identified at an early stage and guide an individualized follow-up. This project can lead to patients who are operated for this devastating cancer disease in the future more than today receive the support and the help they need to improve their quality of life and adaptation to life after surgery.
  • Swedish Research Council
    1 January 2013 - 31 December 2015
  • Swedish Research Council
    1 January 2013 - 31 December 2015
  • Swedish Research Council
    1 January 2011 - 31 December 2012
  • Swedish Research Council
    1 January 2009 - 31 December 2012
  • Swedish Research Council
    1 January 2009 - 31 December 2012

Anställningar

  • Legitimerad sjuksköterska, Tema Cancer, Karolinska Universitetssjukhuset, 2026-
  • Professor på deltid, Imperial College London, 2018-
  • Professor, Molekylär medicin och kirurgi, Karolinska Institutet, 2011-

Examina och utbildning

  • Docent, Vårdvetenskap, Karolinska Institutet, 2010
  • MEDICINE DOKTORSEXAMEN, Institutionen för molekylär medicin och kirurgi, Karolinska Institutet, 2006
  • Sjuksköterskeexamen, Hälsohögskolan, Umeå, 1999

Priser och utmärkelser

  • Hilda och Alfred Erikssons pris, Royal Swedish Academy of Sciences, 2020
  • Eric K. Fernströms pris för yngre, särskilt lovande och framgångsrika forskare vid Karolinska Institutet, Fernströms Foundation, 2018
  • Anders Jahres medicinska forskningspris för unga forskare (nordiskt pris), University of Oslo, 2015
  • Sven och Ebba-Christina Hagbergs forskningspris vid Karolinska Institutet, Sven och Ebba-Christina Hagbergs Stiftelse, 2012
  • Postdoktoralt stipendium från Svenska Sällskapet för Medicinsk Forskning, Swedish Society for Medical Research, 2007

Uppdrag i kommitté

  • Medlem, European Academy of Cancer Sciences, 2012-
  • Medlem, European Collaborative Group on Cancer Survivorship, European Collaborative Group on Cancer Survivorship, 2012-

Gästforskning och resestipendier

  • Gästprofessor vid King's College London, England, King's College London, 2013-2019
  • Post-doc, University of Bristol, 2006-2007

Nyheter från KI

Kalenderhändelser från KI